Renal Cell Cancer Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type



Patients must have histologically or cytologically confirmed RCC (clear cell or non-clear cell allowed, collecting duct or medullary carcinoma excluded).

EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study.